CONMED Corp
Close on Oct 19, 2026
- Market cap
- $1.39B
- P/E (TTM)
- 24.9
- Dividend yield
- 1.30%
About Conmed
Electromedical & Electrotherapeutic Apparatus, SIC 3845
CONMED Corporation is a medical technology company that develops, manufactures, and distributes surgical equipment and clinical devices. The firm operates primarily through two segments: orthopedic surgery and general surgery. Its orthopedic solutions include soft tissue repair implants, sports medicine fixation hardware, visualization tools, and powered bone cutting systems. The general surgery segment supplies smoke evacuation equipment, insufflation systems, electrosurgical generators, endomechanical instruments, and endoscopic devices. These products serve healthcare providers and surgeons across disciplines such as orthopedics, gynecology, thoracic surgery, and gastroenterology, along with hospitals and surgical centers.
The company employs around 3,900 people and produces devices at three main manufacturing locations. Its commercial operations reach more than 100 countries globally through independent distributors and direct sales subsidiaries in regions including Europe, Asia-Pacific, and the Americas. In the United States, it distributes directly to more than 6,000 hospitals and outpatient centers. CONMED is headquartered in Largo, Florida.
Summary of the business section of Conmed's latest annual report, written by StockData.
Company profile
Company
- Legal name
- CONMED Corp
- Founded
- 1970
- Headquarters
- Largo, FL
- Address
- 11311 Concept Boulevard 33773
- Phone
- (727) 214-2974
- Website
- conmed.com
- Employees
- 3,900, Dec 31, 2025
- Industry
- Electromedical & Electrotherapeutic Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, Victor, New York
Stock & identifiers
- Ticker
- CNMD
- Exchange
- NYSE
- IPO date
- Jul 23, 1987
- Shares outstanding
- 30M, Jul 27, 2026
- Public float
- $1.20B, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 3-for-2, Sep 10, 2001; 3-for-2, Dec 1, 1995; 3-for-2, Dec 28, 1994
- SEC CIK
- 816956
- CUSIP
- 207410101
- ISIN
- US2074101013
- LEI
- Z6C0YCECH9DCU5ZIQW84
- EIN
- 16-0977505
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Curt R. Hartman | President and CEO, Director | 93,496 |
| John E. Gallagher | Executive Vice President & CFO | 0 |
| Kimberly Lockwood | Interim Corp Controller & PAO | 1,868 |
| Pat Beyer | President & CEO | 10,807 |
| Brent Lalomia | Executive VP RA, QA | 1,066 |
| Matthew Schabacker | VP GM Advanced Surgical | 0 |
| Hollie K. Foust | General Counsel & Corp Sec | 2,886 |
| Peter K. Shagory | EVP, STRAT & CORP DEVT | 3,897 |
| John D. Ferrell | Executive Vice President - HR | 2,402 |
| Johonna Marie Pelletier | Treasurer and VP, Tax | 4,634 |
| Andrew James Moller | VP Corporate Controller | 0 |
| Richard Glaze | Chief Information Officer | 0 |
| Todd W. Garner | Executive Vice President & CFO | 1,836 |
| Stephan Epinette | VP GM International | 15,510 |
| Edward A. Clifford | VP Global Manufacturing | 500 |
| Kim Kelderman | Director | 500 |
| Celine Christine Martin | Director | 0 |
| Jeffrey B. Mirviss | Director | 0 |
| Mark Kaye | Director | 820 |
| David M. Bronson | Director | 17,909 |
| Charles Farkas | Director | 15,527 |
| Barbara J. Schwarzentraub | Director | 6,454 |
| LaVerne H. Council | Director | 4,716 |
| Brian Concannon | Director | 10,116 |
| Martha Goldberg Aronson | Director | 14,391 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Patrick J. Beyer | $7.63M | $2.52M | $2.09M | $38 | $127 |
| FY2024 Patrick J. Beyer | $7.37M | -$4.77M | $2.77M | $64 | $138 |
| FY2023 Patrick J. Beyer | $7.76M | $13.28M | $2.50M | $101 | $124 |
| FY2022 Patrick J. Beyer | $7.84M | -$8.29M | $3.06M | $81 | $114 |
| FY2021 Patrick J. Beyer | $9.37M | $23.17M | $2.35M | $129 | $140 |
| FY2020 Curt R. Hartman | $6.46M | $8.42M | $1.71M | $101 | $118 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“The Company’s 3,900 employees distribute its products worldwide from three primary manufacturing locations.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 9, 2022 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jun 13, 2022 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| May 26, 2020 | Delisting | Notice of delisting from exchange (Form 25) |
| Feb 10, 2020 | Delisting | Notice of delisting from exchange (Form 25) |
| Feb 6, 2020 | Listing | Registration of securities on an exchange (Form 8-A) |
| Jan 29, 2020 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Feb 11, 2019 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jan 4, 2016 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Aug 24, 2012 | Tender offer | Third-party tender offer for the company's shares |
| Oct 6, 2004 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Apr 1, 2003 | Late filing | Notification of late filing |
| Apr 15, 1998 | Merger | Registration of securities for a merger or exchange offer (S-4) |